Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Raloxifene

Brand: 
NICE TA: 160
Indication: Primary prevention of osteoporotic fragility fractures in postmenopausal women (NICE TA160)
Disease category: Endocrine system
Commissioning responsibility: CCG
PbR excluded: No

Background

LMMG is adopting the local decision made prior to April 2013

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Black

Black

Black

Black

Black

Black